Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_provenance.
- NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_assertion description "[The level of CSF neuroserpin was significantly higher in AD compared with controls and DLB, whereas CSF alpha(1)-antichymotrypsin and alpha(1)-antitrypsin were significantly higher in both AD and DLB groups than in controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_provenance.
- NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_assertion evidence source_evidence_literature NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_provenance.
- NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_assertion SIO_000772 17761554 NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_provenance.
- NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_assertion wasDerivedFrom befree-20140225 NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_provenance.
- NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_assertion wasGeneratedBy ECO_0000203 NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_provenance.
- befree-20140225 importedOn "2014-02-25" NP381162.RALVdaXxhsgRPA1rndsmVFEFsoE_THyqz85MXFVcj4K2A130_provenance.